US Dollar vs MXN

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

ELVN Enliven Therapeutics Inc

24.92

0.00 (0.00%)

Pre Mercado

Última actualización: 06:00:00

Retrasado por 15 minutos

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

All Sales are to be made pursuant to a previously signed/adopted 10b5-1 Selling plan dated 10/19/2023, and all representations regarding material non-public information were made as of the adoption of the plan.

Date of Notice

10/08/2024

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

10/19/2023

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

Rahul Ballal

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Enliven Therapeutics (NASDAQ:ELVN)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024

Haga Click aquí para más Gráficas Enliven Therapeutics.

Enliven Therapeutics (NASDAQ:ELVN)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024

Haga Click aquí para más Gráficas Enliven Therapeutics.

Noticias sobre Enliven Therapeutics Inc ELVN

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jueves 14 de Noviembre 2024 (14 horas hace) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jueves 14 de Noviembre 2024 (16 horas hace) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jueves 14 de Noviembre 2024 (16 horas hace) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Miércoles 13 de Noviembre 2024 (2 días hace) • Edgar (US Regulatory)

Enliven Therapeutics Reports Third Quarter Financial Results and Provides a Business Update
Miércoles 13 de Noviembre 2024 (2 días hace) • PR Newswire (US)

Enliven Therapeutics to Present at the Jefferies London Healthcare Conference
Jueves 7 de Noviembre 2024 (1 semana hace) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Miércoles 30 de Octubre 2024 (2 semanas hace) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Jueves 24 de Octubre 2024 (3 semanas hace) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Martes 22 de Octubre 2024 (3 semanas hace) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Martes 22 de Octubre 2024 (3 semanas hace) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Martes 22 de Octubre 2024 (3 semanas hace) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Martes 22 de Octubre 2024 (3 semanas hace) • Edgar (US Regulatory)

Más de Enliven Therapeutics Inc Artículos de Noticias

Health Care Select Sector

Financial Select Sector

Bank of America

Gold vs US Dollar

JP Morgan Chase

Deutsche Telekom (QX)

Energy Select Sector SPDR

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones